Their common features may inform manufacturer behaviour and guide policy measures in the US and other high income countries. Multiple parallels exist between covid-19 and influenza vaccines with respect to their development history, market, and administration. After the pandemic, however, the future pricing landscape of covid-19 vaccines remains unclear. Bilateral bulk purchasing agreements between individual countries and manufacturers have allowed vaccines to be procured at lower prices and dispensed to patients without charges. Yet evidence is emerging that the novel coronavirus will continue to evolve and that immunity from vaccines is likely to be time limited, requiring use of booster doses or modified vaccines. The increasing availability of covid-19 vaccines has signalled to many the beginning of the end of a devastating pandemic. Routine use of covid-19 vaccines could strain health budgets if pricing follows the pattern seen with influenza vaccines, say Reshma Ramachandran and colleagues
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |